AlloCure Inc. Appoints Kevin J. Heyeck as Chief Business Officer
2/14/2011 8:47:40 AM
BURLINGTON, Mass.--(BUSINESS WIRE)--AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J. Heyeck as Chief Business Officer. Mr. Heyeck, who brings more than twenty years of experience in business development leadership and corporate partnering for emerging pharmaceutical companies, previously led business development efforts at Vitae Pharmaceuticals, and before that, Pharmacopeia.
comments powered by